Sposab Abp 501: A Sicilian Prospective Observational Study Of Patients With Inflammatory Bowel Disease Treated With Adalimumab Biosimilar Abp 501
DIGESTIVE AND LIVER DISEASE（2021）
摘要
Safety and effectiveness of ABP 501 seem to be overall similar to those reported for ADA originator. Switching from originator to ABP 501 was safe and effective.
更多查看译文
关键词
Biosimilar,Real-world,Safety,Switch
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要